The types of acquisitions available to you

Full sale

You sell all of the business, receive the great majority of value at closing, and transition out over an agreed period, often 30 days to a year. This is the cleanest exit and the right choice when you are ready to be finished. Some cash may still sit in escrow or an earnout, so read those terms closely.

Recapitalization

You sell a majority stake, usually 60 to 80 percent, take most of the value now, and keep the rest as equity in the business going forward. You typically stay involved with real authority over clinical and cultural decisions while the buyer supplies capital, back office capability, and acquisition experience. This is the most common structure for owners in their forties and fifties who are not done working.

Growth partnership

A minority investment where you keep control and take partial liquidity, often to fund new sites, recruitment, or an acquisition of your own. Less common in smaller practices, because most investors want control at this size, but it exists for businesses with strong momentum.

Rollover equity, explained plainly

Rollover equity means you reinvest part of your sale proceeds into the acquiring company instead of taking all cash. If you sell for five million dollars with 20 percent rollover, you receive four million in cash and hold one million of equity in the buyer's platform.

The reason owners do this is the multiple gap. Your practice might sell at a mid single digit multiple, while the platform that owns dozens of practices may trade at a much higher one. When the platform sells three to six years later, your rolled stake is valued at the platform multiple, and that second payment can exceed your first one.

The risk is real and worth stating plainly. Rolled equity is illiquid, you do not control the timing of the next sale, and if the platform underperforms your stake can be worth less than the cash you gave up. Before agreeing, understand which class of equity you receive, whether it sits behind preferred capital, what happens if you leave, and what governance or information rights you keep.

Typical rollover range

Most healthcare transactions with rollover fall between 10 and 40 percent of value.

Same class matters

Rolling into the same security the sponsor holds aligns you with them; rolling into a junior class does not.

Time horizon

Expect the platform to seek its own sale in roughly three to six years.

Tax treatment

Properly structured rollover can defer tax on the rolled portion. Confirm with your own tax counsel.

Other terms that decide your outcome

Structure choice is only part of the negotiation. These terms move real money.

Earnout

Contingent payment tied to future results. Insist on targets you control and on clear measurement.

Working capital peg

The level of receivables and payables you must leave behind. A wrong peg quietly costs six figures.

Escrow and indemnity

How much is held back, for how long, and against which risks.

Employment and non compete

Your role, pay, authority, and how long you are restricted afterward.

Asset vs. Stock Purchases

In the healthcare world, the structure of the deal is just as important as the price. In an asset purchase, the buyer only buys specific assets (like equipment, patient lists, and contracts) and leaves behind the corporate entity and its liabilities. This is often preferred by buyers to avoid hidden legal risks. In a stock purchase, the buyer acquires the entire company, including all its history and liabilities. Sellers often prefer stock sales for their favorable tax treatment.

The choice between asset and stock deals has significant implications for Medicare and Medicaid providers. A Change of Ownership (CHOW) can be triggered in either case, but the process for transferring provider agreements differs. According to CMS guidelines, a CHOW involves the substitution of one person established as the provider for another. Understanding these definitions is vital for a smooth transition and to avoid disruptions in billing and patient care.

Strategic vs. Financial Acquisitions

Buyers generally fall into two categories: strategic and financial. Strategic buyers are existing healthcare companies looking to expand their footprint or service lines. An example is Addus HomeCare's acquisition of Gentiva's personal care operations to grow their scale. Financial buyers, like private equity firms, look for businesses they can grow and sell later. Goldman Sachs Alternatives' acquisition of Center for Social Dynamics in 2024 is a classic example of a financial-led transaction.

Financial buyers often use a 'Platform' strategy, where they buy a large practice and then 'bolt on' smaller acquisitions. Mertz Taggart's Q1 2024 report showed this mix, with 24 control M&A deals and 18 growth-equity deals. Financial buyers may also offer 'Rollover Equity,' where the seller keeps a minority stake in the new entity. This allows the seller to participate in the future upside when the private equity firm eventually exits the business.

Consolidation and Roll-ups

A 'roll-up' is a strategy where a buyer acquires many small practices in the same industry to create one large company. This is common in fragmented markets like ABA therapy or home care. Fletch Equity's acquisition of Autism Spectrum Interventions in 2024 was their 13th in just 33 months, a prime example of a serial acquisition strategy. For a seller, being part of a roll-up can provide access to better technology and deeper resources than they had as a standalone entity.

However, large-scale consolidation is facing increased scrutiny. The March 2024 inquiry by the DOJ, FTC, and HHS into healthcare ownership signals that regulators are looking closely at how these deals affect competition and patient care. Sellers should ensure their business is beyond reproach, as any red flags during due diligence will be magnified in this high-scrutiny environment. This guide does not constitute legal advice; always consult a professional for your specific situation.